PAVmed
PAVM
52 hedge funds and large institutions have $14.2M invested in PAVmed in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.
560% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 5
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
117% more funds holding
Funds holding: 24 → 52 (+28)
111% more capital invested
Capital invested by funds: $6.73M → $14.2M (+$7.46M)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.7M |
| 2 |
State Street
Boston,
Massachusetts
|
+$794K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$741K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$612K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$410K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
-$716K |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$224K |
| 3 |
SIM
Spark Investment Management
New York
|
-$130K |
| 4 |
SF
Synovus Financial
Columbus,
Georgia
|
-$79K |
| 5 |
MRCM
M&R Capital Management
Summit,
New Jersey
|
-$54K |
PAVM Hedge Fund Activity: Q2 2020 in Review
52 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2020, worth a combined $14.2M — up 111% from $6.73M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new PAVM positions and 5 closed out — a net gain of 28 holders — while 10 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, adding an estimated $3.7M. The largest seller was Belpointe Asset Management, cutting an estimated $716K.
- 52 institutional investors held PAVmed (PAVM) as of Q2 2020, up from 24 in Q1 2020.
- Funds reported $14.2M of PAVmed stock for Q2 2020, up 111% quarter-over-quarter.
- 33 funds opened new PAVmed positions in Q2 2020 and 5 closed out, a net change of +28 holders.
- The largest PAVmed buyer in Q2 2020 was BlackRock, an estimated $3.7M added.
- The largest PAVmed seller in Q2 2020 was Belpointe Asset Management, an estimated $716K sold.
Based on aggregated 13F filings for Q2 2020.